Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178345 · ClinicalTrials.gov registry record
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 123
- Enrollment target
NCT02178345: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02178345 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02178345 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. Perfusion MRI uses faster imaging. It also includes a contrast material that is given by vein. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. Perfusion and diffusion MRI give extra information which is not available with the regular MRI. A regular MRI only shows pictures of the tumor. Thyroid MRI scans are not part of the current standard of care. The purpose of this study is to see if new MRI methods can give us more information about the tumor.
Primary Outcome
The long-term goal of this work will be to perform clinical trials of personalized management approach, in which imaging biomarkers are used to recommend either immediate surgery or active surveillance for PTC patients.
Interventions
- PROCEDURE diffusion weighted (DW) MRI
- PROCEDURE dynamic contrast agent (DCE) MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2014-06-24 |
| Est. Completion | 2021-12-03 |
What the finished NCT02178345 record still lists
NCT02178345 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which diffusion weighted (DW) MRI is the first listed.
NCT02178345 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02178345 about?
NCT02178345 is a clinical study titled "Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer". Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. Perfusion MRI uses faster imaging. It also includes a contrast material that is given by vein. This makes specific organs, blood vessels,...
What is the current status of trial NCT02178345?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2014-06-24. Estimated completion is 2021-12-03.
What interventions are being tested in trial NCT02178345?
The interventions under investigation include: diffusion weighted (DW) MRI (PROCEDURE), dynamic contrast agent (DCE) MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02178345?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI